Advertisement

PolyPid Ltd. PYPD

Set alert

Price alert · PYPD

All alert types
5.39 USD -0.20 -3.58%

At close · Oct 30

5.45 +0.06 +1.11%

After hours · Oct 30, 6:25 PM ET

Bid
5.39 × 1
Ask
5.42 × 1
5.39 Day range 5.59
3.58 52-week range 5.78
YTD
+24.19%
1 year
+40.36%
Open
5.54
Prev close
5.59
Mkt cap
109.48M
Vol
101.56K
Avg vol
118.58K
EPS
-1.44
P/E
0.00
Div yield
0.00%
More statistics
Low
5.39
High
5.59
Forward P/E
-1.36
Beta
1.32
Short ratio
2.29
Inst. own
36.75%
Dividend
0.00
Ex-div date
Earnings
Feb 12, 2025
50-d avg
3.28
200-d avg
3.90
1y target
11.75

MAX chart

Chart tools
Interval

Events in this range
  • Sep 21, 2023Split: 1 for 30
  • May 8, 2024Earnings: -1.37; estimate -1.96; surprise 30.1%
  • May 8, 2024Earnings: —; estimate -1.96; surprise —%
  • May 9, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Jun 18, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Aug 14, 2024Earnings: -1.25; estimate -1.51; surprise 17.22%
  • Aug 14, 2024Earnings: —; estimate -1.51; surprise —%
  • Aug 15, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Oct 2, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Nov 4, 2024Rating: Craig-Hallum · — → Buy
  • Nov 13, 2024Earnings: -1.22; estimate -1.07; surprise -14.02%
  • Dec 16, 2024Rating: HC Wainwright & Co. · Buy → Buy
  • Feb 12, 2025Earnings: —; estimate -1.05; surprise —%
Signals (119)
NameDateAgo
MACD: Buy SignalOct 26, 20265 days ago
SMA: BullishOct 19, 20261 week ago
SMA: BullishOct 19, 20261 week ago
SMA: BearishOct 12, 20262 weeks ago
MACD: Sell SignalOct 12, 20262 weeks ago
SMA: BearishOct 5, 20263 weeks ago
MACD: Buy SignalAug 24, 20262 months ago
SMA: BullishAug 17, 20262 months ago
SMA: BearishAug 10, 20262 months ago
SMA: BullishAug 3, 20262 months ago
SMA: BullishAug 3, 20262 months ago
SMA: BearishJul 20, 20263 months ago
SMA: BearishJul 20, 20263 months ago
MACD: Sell SignalJul 20, 20263 months ago
MACD: Buy SignalJun 29, 20264 months ago
SMA: BullishJun 8, 20264 months ago
SMA: BearishJun 1, 20265 months ago
MACD: Sell SignalJun 1, 20265 months ago
MACD: Buy SignalMay 18, 20265 months ago
SMA: BullishMar 30, 20267 months ago
MACD: Sell SignalFeb 23, 20268 months ago
SMA: BearishFeb 16, 20268 months ago
RSI: OverboughtJan 5, 20269 months ago
MACD: Buy SignalOct 27, 20251 year ago
SMA: BullishOct 20, 20251 year ago
SMA: BullishOct 13, 20251 year ago
SMA: BearishOct 6, 20251 year ago
SMA: BearishOct 6, 20251 year ago
MACD: Sell SignalOct 6, 20251 year ago
SMA: BullishSep 29, 20251 year ago
SMA: BearishSep 15, 20251 year ago
SMA: BullishSep 8, 20251 year ago
SMA: BearishAug 25, 20251 year ago
SMA: BearishAug 4, 20251 year ago
SMA: BullishJun 2, 20251 year ago
SMA: BullishApr 28, 20251 year ago
MACD: Buy SignalApr 28, 20251 year ago
MACD: Sell SignalMar 31, 20251 year ago
SMA: BearishMar 3, 20251 year ago
SMA: BullishFeb 24, 20251 year ago
SMA: BearishFeb 10, 20251 year ago
SMA: BullishFeb 3, 20251 year ago
SMA: BearishJan 27, 20251 year ago
SMA: BullishJan 13, 20251 year ago
RSI: OversoldDec 9, 20241 year ago
SMA: BearishNov 25, 20241 year ago
SMA: BullishNov 4, 20241 year ago
SMA: BearishOct 21, 20242 years ago
SMA: BullishOct 14, 20242 years ago
SMA: BearishOct 7, 20242 years ago
SMA: BullishSep 23, 20242 years ago
SMA: BearishMay 27, 20242 years ago
SMA: BullishMay 20, 20242 years ago
SMA: BearishMar 4, 20242 years ago
SMA: BullishFeb 26, 20242 years ago
SMA: BearishFeb 19, 20242 years ago
SMA: BearishFeb 19, 20242 years ago
SMA: BullishJan 29, 20242 years ago
SMA: BearishJan 8, 20242 years ago
SMA: BullishJan 1, 20242 years ago
SMA: BullishJan 1, 20242 years ago
SMA: BearishDec 18, 20232 years ago
RSI: OversoldDec 11, 20232 years ago
SMA: BullishNov 27, 20232 years ago
RSI: OversoldAug 28, 20233 years ago
SMA: BearishAug 7, 20233 years ago
SMA: BullishJul 31, 20233 years ago
SMA: BearishJul 17, 20233 years ago
RSI: OversoldJul 17, 20233 years ago
SMA: BullishJul 3, 20233 years ago
SMA: BearishJun 19, 20233 years ago
SMA: BullishMay 29, 20233 years ago
RSI: OversoldFeb 13, 20233 years ago
SMA: BearishJan 30, 20233 years ago
MACD: Buy SignalDec 12, 20223 years ago
SMA: BearishAug 29, 20224 years ago
SMA: BearishAug 29, 20224 years ago
MACD: Sell SignalAug 29, 20224 years ago
RSI: OversoldAug 29, 20224 years ago
SMA: BullishJul 25, 20224 years ago
SMA: BullishJul 18, 20224 years ago
SMA: BearishJun 6, 20224 years ago
SMA: BullishMay 30, 20224 years ago
SMA: BearishApr 25, 20224 years ago
SMA: BullishApr 18, 20224 years ago
SMA: BearishApr 11, 20224 years ago
SMA: BullishMar 14, 20224 years ago
MACD: Buy SignalMar 14, 20224 years ago
SMA: BearishMar 7, 20224 years ago
SMA: BullishFeb 28, 20224 years ago
RSI: OversoldJan 24, 20224 years ago
MACD: Sell SignalNov 29, 20214 years ago
SMA: BearishNov 8, 20214 years ago
SMA: BullishNov 1, 20215 years ago
MACD: Buy SignalNov 1, 20215 years ago
MACD: Sell SignalOct 25, 20215 years ago
SMA: BearishSep 6, 20215 years ago
SMA: BullishAug 23, 20215 years ago
MACD: Buy SignalAug 9, 20215 years ago
MACD: Sell SignalJul 12, 20215 years ago
SMA: BearishJun 28, 20215 years ago
SMA: BullishJun 21, 20215 years ago
SMA: BearishMay 31, 20215 years ago
SMA: BullishMay 17, 20215 years ago
MACD: Buy SignalMay 17, 20215 years ago
MACD: Sell SignalMay 3, 20215 years ago
SMA: BearishMar 1, 20215 years ago
SMA: BearishFeb 22, 20215 years ago
SMA: BullishFeb 8, 20215 years ago
SMA: BullishFeb 8, 20215 years ago
SMA: BearishJan 18, 20215 years ago
SMA: BullishJan 4, 20215 years ago
SMA: BearishDec 21, 20205 years ago
SMA: BullishDec 7, 20205 years ago
SMA: BearishNov 30, 20205 years ago
SMA: BullishNov 23, 20205 years ago
RSI: OversoldNov 16, 20205 years ago
SMA: BearishOct 19, 20206 years ago
SMA: BullishOct 12, 20206 years ago

Key statistics

Market cap
25.04M
Enterprise value
18.09M
Trailing P/E
0.00
Forward P/E
-1.36
PEG ratio
0.00
Price / sales
0.00
Price / book
0.00
EPS (TTM)
-7.22
Beta
1.32
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
0.00%
Revenue (TTM)
0
Revenue growth
0.00%
Free cash flow
-9.82M
Total cash
9.35M
Total debt
11.03M
Return on equity
-496.62%
Shares outstanding
6.80M
Short % of float
0.28%
50-day average
3.28
200-day average
3.90

Analyst view

Consensus: buy

Buy
Price target (mean) 11.75 +118.0% upside
Target (low)
10.00
Target (mean)
11.75
Target (high)
14.00
Ratings (0m) 4 3 buy · 1 hold · 0 sell
  • Strong buy2
  • Buy1
  • Hold1
  • Sell0
  • Strong sell0

Next earnings

Feb 12, 2025

Expected Feb 12, 2025. Consensus EPS estimate -1.03.

Earnings history

Financials — quick view

All financials
PYPD Revenue — quarterly 0
2021-Q3 20212021-Q4 20212022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242025-Q1 20252025-Q2 2025
PYPD Net income — quarterly -9.98M
2021-Q3 20212021-Q4 20212022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242025-Q1 20252025-Q2 2025
PYPD EPS — quarterly -0.78
2021-Q3 20212021-Q4 20212022-Q2 20222022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242025-Q1 20252025-Q2 2025

Earnings

PYPD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 12, 2025Dec 1, 2024-1.05———
Nov 13, 2024Sep 1, 2024-1.07-1.22-0.15-14.02%
Aug 14, 2024Jun 1, 2024-1.51-1.25+0.26+17.22%
Aug 14, 2024Jun 1, 2024-1.51———
May 8, 2024Mar 1, 2024-1.96-1.37+0.59+30.10%
May 8, 2024Mar 1, 2024-1.96———

Upgrades / downgrades

PYPD analyst upgrades and downgrades
DateFirmActionFromTo
Dec 16, 2024HC Wainwright & Co.reitBuyBuy
Nov 4, 2024Craig-Halluminit—Buy
Oct 2, 2024HC Wainwright & Co.reitBuyBuy
Aug 15, 2024HC Wainwright & Co.reitBuyBuy
Jun 18, 2024HC Wainwright & Co.reitBuyBuy
May 9, 2024HC Wainwright & Co.reitBuyBuy

About PolyPid Ltd.

PolyPid Ltd., a clinical-stage biopharmaceutical company, developing targeted, locally administered, and prolonged-release therapeutics using its proprietary polymer-lipid encapsulation matrix (PLEX) technology to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in a pivotal Phase 3 confirmatory trial for prevention of surgical site infections (SSIs) in patients undergoing abdominal colorectal surgery with large incisions. It is also developing OncoPLEX, for the treatment of intra-tumoral cancer. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Sector
Healthcare
Industry
Biotechnology
Country
Israel
Website
polypid.com

News

Your note

Sign in to keep a note on PYPD — it syncs with the Stock Master app.

Institution ownership

PYPD institution ownership
Holder% heldSharesValueReported
AIGH Capital Management LLC9.99%679,6682.50MSep 29, 2024
Rosalind Advisors, Inc.9.98%679,1682.50MSep 29, 2024
DAFNA Capital Management, LLC4.53%308,4971.14MSep 29, 2024
Stonepine Capital Management, LLC2.04%138,504509.69KSep 29, 2024
Adar1 Capital Management, LLC 1.38%93,902345.56KSep 29, 2024
Yelin Lapidot Holdings Management Ltd.0.16%11,15341.04KSep 29, 2024

Fund ownership

PYPD fund ownership
Holder% heldSharesValueReported
Fidelity NASDAQ Composite Index Fund0.00%80294Oct 30, 2024
Advertisement